Andrew Bzowyckyj/LinkedIn
Aug 1, 2026, 05:49
Andrew Bzowyckyj: New Therapies Transforming Chronic Kidney Disease Care
Andrew Bzowyckyj, Senior Scientific Director, Learning Consultant at National Kidney Foundation, shared a post on LinkedIn:
“Managing chronic kidney disease (CKD) has become increasingly complex, due in part to a rapid and promising increase in the number of pharmacologic therapies now available to slow CKD progression and reduce its associated cardiovascular risk.”
Stay updated with Hemostasis Today.
-
Aug 1, 2026, 11:07Yashaswi Dhiman: Advancing Hemovigilance Through Award-Winning Science
-
Aug 1, 2026, 08:24Kayla Garrett: Transforming Expectations in Haemophilia A Care
-
Aug 1, 2026, 07:51Toyosi Onwuemene: Are We Measuring the Outcomes That Matter Most to Patients With TTP?
-
Aug 1, 2026, 07:51Christopher Kirkham: Could Platelet Activation Become a Liability for Your Antibody Programme?
-
Aug 1, 2026, 07:38Danny Hsu: Recognizing Excellence in Scientific Leadership at ISTH 2026
-
Aug 1, 2026, 07:24Ulrich Sachs: A New Strategy to Prevent Platelet Transfusion Refractoriness
-
Aug 1, 2026, 07:12Gijs Aertssen: New Evidence on Joint Prosthesis Survival in Inherited Bleeding Disorders
-
Aug 1, 2026, 06:58Nora Abazi Emini: New Insights into Factor XIII in Atypical Haemolytic Uraemic Syndrome
-
Aug 1, 2026, 06:30Understanding Natural Anticoagulant Deficiencies – JTH